PolyNovo Limited (ASX: PNV)

Market Cap	1.53B
Revenue (ttm)	103.23M
Net Income (ttm)	5.26M
Shares Out	690.84M
EPS (ttm)	0.01
PE Ratio	294.67
Forward PE	179.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,449,528
Average Volume	961,660
Open	2.200
Previous Close	2.200
Day's Range	2.200 - 2.280
52-Week Range	1.775 - 2.780
Beta	1.72
RSI	63.00
Earnings Date	Feb 24, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MT...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 254
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PNV